Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint
Konstan, M.W, Wagener, J.S, Yegin, A, Millar, S.J, Pasta, D.J, VanDevanter, D.R
Published in Journal of cystic fibrosis (01.09.2010)
Published in Journal of cystic fibrosis (01.09.2010)
Get full text
Journal Article
Early inflammation and the development of pulmonary disease in cystic fibrosis
Wagener, J.S., Kahn, T.Z., Copenhaver, S.C., Accurso, F.J.
Published in Pediatric pulmonology (01.01.1997)
Published in Pediatric pulmonology (01.01.1997)
Get full text
Journal Article